Tharimmune (THAR) Short Interest Ratio & Short Volume → 😱 This phenomenon is smashing regular market gains (From MillPub) (Ad) Free THAR Stock Alerts $0.36 0.00 (0.00%) (As of 04/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Tharimmune Short Interest DataCurrent Short Volume103,400 sharesPrevious Short Volume75,300 sharesChange Vs. Previous Month+37.32%Dollar Volume Sold Short$37,337.74Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares11,740,000 sharesFloat Size11,530,000 sharesShort Percent of Float0.90%Today's Trading Volume38,408 sharesAverage Trading Volume199,456 sharesToday's Volume Vs. Average19% Short Selling Tharimmune ? Sign up to receive the latest short interest report for Tharimmune and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTHAR Short Interest Over TimeTHAR Days to Cover Over TimeTHAR Percentage of Float Shorted Over Time Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. Tharimmune Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024103,400 shares $37,337.74 +37.3%0.9%0.2 $0.36 3/31/202475,300 shares $32,394.06 +230.3%0.7%0.1 $0.43 3/15/202422,800 shares $8,094.00 -69.9%0.2%0 $0.36 2/29/202475,700 shares $29,121.79 +44.2%0.7%0.1 $0.38 2/15/202452,500 shares $20,412.00 -75.7%0.5%0 $0.39 1/31/2024216,000 shares $95,040.00 No Change1.3%0.2 $0.44 THAR Short Interest - Frequently Asked Questions What is Tharimmune's current short interest? Short interest is the volume of Tharimmune shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 103,400 shares of THAR short. 0.90% of Tharimmune's shares are currently sold short. Learn More on Tharimmune's current short interest. What is a good short interest percentage for Tharimmune? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.90% of Tharimmune's floating shares are currently sold short. Is Tharimmune's short interest increasing or decreasing? Tharimmune saw a increase in short interest in April. As of April 15th, there was short interest totaling 103,400 shares, an increase of 37.3% from the previous total of 75,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tharimmune's float size? Tharimmune currently has issued a total of 11,740,000 shares. Some of Tharimmune's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tharimmune currently has a public float of 11,530,000 shares. How does Tharimmune's short interest compare to its competitors? 0.90% of Tharimmune's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tharimmune: Petros Pharmaceuticals, Inc. (1.69%), Cingulate Inc. (0.58%), Artelo Biosciences, Inc. (0.19%), Longeveron Inc. (9.34%), Exicure, Inc. (2.01%), Lipella Pharmaceuticals Inc. (1.49%), NexImmune, Inc. (0.89%), Genprex, Inc. (2.69%), Avenue Therapeutics, Inc. (32.81%), Seelos Therapeutics, Inc. (5.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Tharimmune stock? Short selling THAR is an investing strategy that aims to generate trading profit from Tharimmune as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tharimmune? A short squeeze for Tharimmune occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of THAR, which in turn drives the price of the stock up even further. How often is Tharimmune's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including THAR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Petros Pharmaceuticals Short Squeeze Cingulate Short Squeeze Artelo Biosciences Short Squeeze Longeveron Short Squeeze Exicure Short Squeeze Lipella Pharmaceuticals Short Squeeze NexImmune Short Squeeze Genprex Short Squeeze Avenue Therapeutics Short Squeeze Seelos Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:THAR) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders😱 This phenomenon is smashing regular market gainsMillPubHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceYour bank is lying to you.MyBankTracker#1 election stockPorter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority Gold